Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders.

Journal: Open biology

Volume: 11

Issue: 10

Year of Publication: 2022

Affiliated Institutions:  Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa. South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa. Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Abstract summary 

Synaptopathies are brain disorders characterized by dysfunctional synapses, which are specialized junctions between neurons that are essential for the transmission of information. Synaptic dysfunction can occur due to mutations that alter the structure and function of synaptic components or abnormal expression levels of a synaptic protein. One class of synaptic proteins that are essential to their biology are cell adhesion proteins that connect the pre- and post-synaptic compartments. Neurexins are one type of synaptic cell adhesion molecule that have, recently, gained more pathological interest. Variants in both neurexins and their common binding partners, neuroligins, have been associated with several neuropsychiatric disorders. In this review, we summarize some of the key physiological functions of the neurexin protein family and the protein networks they are involved in. Furthermore, examination of published literature has implicated neurexins in both neuropsychiatric and neurodegenerative disorders. There is a clear link between neurexins and neuropsychiatric disorders, such as autism spectrum disorder and schizophrenia. However, multiple expression studies have also shown changes in neurexin expression in several neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. Therefore, this review highlights the potential importance of neurexins in brain disorders and the importance of doing more targeted studies on these genes and proteins.

Authors & Co-authors:  Cuttler Katelyn K Hassan Maryam M Carr Jonathan J Cloete Ruben R Bardien Soraya S

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Torres VI, Vallejo D, Inestrosa NC. 2017. Emerging synaptic molecules as candidates in the etiology of neurological disorders. Neural Plast. 2017, 8081758. (10.1155/2017/8081758)
Authors :  5
Identifiers
Doi : 210091
SSN : 2046-2441
Study Population
Male,Female
Mesh Terms
Animals
Other Terms
neurexin;neurodegenerative disorders;neuroligin;neuropsychiatric disorders;protein interactions;synapse
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
England